3RU4
 
 | Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin | 分子名称: | (4R)-2-METHYLPENTANE-2,4-DIOL, 1,2-ETHANEDIOL, Bowman-Birk type seed trypsin and chymotrypsin inhibitor, ... | 著者 | Esteves, G.F, Santos, C.R, Ventura, M.M, Barbosa, J.A.R.G, Freitas, S.M. | 登録日 | 2011-05-04 | 公開日 | 2012-08-29 | 最終更新日 | 2024-11-20 | 実験手法 | X-RAY DIFFRACTION (1.68 Å) | 主引用文献 | Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin To be Published
|
|
1OAD
 
 | Glucose isomerase from Streptomyces rubiginosus in P21212 crystal form | 分子名称: | (4R)-2-METHYLPENTANE-2,4-DIOL, (4S)-2-METHYL-2,4-PENTANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ... | 著者 | Ramagopal, U.A, Dauter, M, Dauter, Z. | 登録日 | 2003-01-08 | 公開日 | 2003-01-30 | 最終更新日 | 2024-05-08 | 実験手法 | X-RAY DIFFRACTION (1.5 Å) | 主引用文献 | Sad Manganese in Two Crystal Forms of Glucose Isomerase Acta Crystallogr.,Sect.D, 59, 2003
|
|
3WL2
 
 | Monoclinic Lysozyme at 0.96 A resolution | 分子名称: | 1,2-ETHANEDIOL, Lysozyme C, NITRATE ION, ... | 著者 | Matsumoto, T, Yamano, A, Hasegawa, T, Maeyama, M. | 登録日 | 2013-11-06 | 公開日 | 2014-11-12 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (0.96 Å) | 主引用文献 | Evaluation of Rigaku XtaLAB P200 To be Published
|
|
1QJX
 
 | HUMAN RHINOVIRUS 16 COAT PROTEIN IN COMPLEX WITH ANTIVIRAL COMPOUND WIN68934 | 分子名称: | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL, MYRISTIC ACID, PROTEIN VP1, ... | 著者 | Hadfield, A.T, Diana, G.D, Rossmann, M.G. | 登録日 | 1999-07-06 | 公開日 | 1999-07-20 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.8 Å) | 主引用文献 | Analysis of Three Structurally Related Antiviral Compounds in Complex with Human Rhinovirus 16 Proc.Natl.Acad.Sci.USA, 96, 1999
|
|
3S3Q
 
 | Structure of cathepsin B1 from Schistosoma mansoni in complex with K11017 inhibitor | 分子名称: | ACETATE ION, Cathepsin B-like peptidase (C01 family), N~2~-(morpholin-4-ylcarbonyl)-N-[(3S)-1-phenyl-5-(phenylsulfonyl)pentan-3-yl]-L-leucinamide | 著者 | Rezacova, P, Jilkova, A, Brynda, J, Horn, M, Mares, M. | 登録日 | 2011-05-18 | 公開日 | 2011-08-10 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni. J.Biol.Chem., 286, 2011
|
|
2ASF
 
 | Crystal structure of the conserved hypothetical protein Rv2074 from Mycobacterium tuberculosis 1.6 A | 分子名称: | CITRIC ACID, Hypothetical protein Rv2074, SODIUM ION | 著者 | Biswal, B.K, Au, K, Cherney, M.M, Garen, C, James, M.N, TB Structural Genomics Consortium (TBSGC) | 登録日 | 2005-08-23 | 公開日 | 2005-10-11 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution. Acta Crystallogr.,Sect.F, 62, 2006
|
|
3N1W
 
 | Human FPPS COMPLEX WITH FBS_02 | 分子名称: | (5-chloro-1-benzothiophen-3-yl)acetic acid, FARNESYL PYROPHOSPHATE SYNTHASE, PHOSPHATE ION | 著者 | Rondeau, J.-M. | 登録日 | 2010-05-17 | 公開日 | 2010-08-18 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.56 Å) | 主引用文献 | Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery. Nat.Chem.Biol., 6, 2010
|
|
3CNH
 
 | |
2WDB
 
 | A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,2) mannose | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose, CALCIUM ION, HYALURONOGLUCOSAMINIDASE | 著者 | Ficko-Blean, E, Boraston, A.B. | 登録日 | 2009-03-23 | 公開日 | 2009-05-05 | 最終更新日 | 2024-05-08 | 実験手法 | X-RAY DIFFRACTION (2.03 Å) | 主引用文献 | N-Acetylglucosamine Recognition by a Family 32 Carbohydrate-Binding Module from Clostridium Perfringens Nagh. J.Mol.Biol., 390, 2009
|
|
1HFF
 
 | NMR solution structures of the vMIP-II 1-10 peptide from Kaposi's sarcoma-associated herpesvirus. | 分子名称: | VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II | 著者 | Crump, M.P, Elisseeva, E, Gong, J.H, Clark-Lewis, I, Sykes, B.D. | 登録日 | 2000-12-01 | 公開日 | 2000-12-07 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10) FEBS Lett., 489, 2001
|
|
1HFG
 
 | NMR solution structure of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus (minimized average structure). | 分子名称: | VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II | 著者 | Crump, M.P, Elisseeva, E, Gong, J.-H, Clark-Lewis, I, Sykes, B.D. | 登録日 | 2000-12-01 | 公開日 | 2001-01-07 | 最終更新日 | 2024-10-09 | 実験手法 | SOLUTION NMR | 主引用文献 | Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10) FEBS Lett., 489, 2001
|
|
3CR4
 
 | X-ray structure of bovine Pnt,Ca(2+)-S100B | 分子名称: | 1,5-BIS(4-AMIDINOPHENOXY)PENTANE, CALCIUM ION, Protein S100-B | 著者 | Charpentier, T.H. | 登録日 | 2008-04-04 | 公開日 | 2008-08-05 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.15 Å) | 主引用文献 | Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J.Mol.Biol., 382, 2008
|
|
2QEU
 
 | |
3UV5
 
 | Crystal Structure of the tandem bromodomains of human Transcription initiation factor TFIID subunit 1 (TAF1) | 分子名称: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Transcription initiation factor TFIID subunit 1 | 著者 | Filippakopoulos, P, Felletar, I, Picaud, S, Keates, T, Muniz, J, Gileadi, O, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Weigelt, J, Bountra, C, Knapp, S, Structural Genomics Consortium (SGC) | 登録日 | 2011-11-29 | 公開日 | 2012-01-18 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.03 Å) | 主引用文献 | Histone recognition and large-scale structural analysis of the human bromodomain family. Cell(Cambridge,Mass.), 149, 2012
|
|
3V4Y
 
 | Crystal Structure of the first Nuclear PP1 holoenzyme | 分子名称: | GLYCEROL, MANGANESE (II) ION, Nuclear inhibitor of protein phosphatase 1, ... | 著者 | Page, R, Peti, W, O'Connell, N.E, Nichols, S. | 登録日 | 2011-12-15 | 公開日 | 2012-10-31 | 最終更新日 | 2024-02-28 | 実験手法 | X-RAY DIFFRACTION (2.098 Å) | 主引用文献 | The Molecular Basis for Substrate Specificity of the Nuclear NIPP1:PP1 Holoenzyme. Structure, 20, 2012
|
|
7JJG
 
 | |
2QNP
 
 | HIV-1 Protease in complex with a iodo decorated pyrrolidine-based inhibitor | 分子名称: | CHLORIDE ION, Gag-Pol polyprotein (Pr160Gag-Pol), N,N'-(3S,4S)-pyrrolidine-3,4-diylbis[N-(4-iodobenzyl)benzenesulfonamide] | 著者 | Boettcher, J, Blum, A, Heine, A, Diederich, W.E, Klebe, G. | 登録日 | 2007-07-19 | 公開日 | 2008-04-15 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (1.41 Å) | 主引用文献 | Structure-Guided Design of C2-Symmetric HIV-1 Protease Inhibitors Based on a Pyrrolidine Scaffold. J.Med.Chem., 51, 2008
|
|
4HKL
 
 | Crystal Structures of Mutant Endo-beta-1,4-xylanase II Complexed with substrate (1.15 A) and Products (1.6 A) | 分子名称: | Endo-1,4-beta-xylanase 2, IODIDE ION | 著者 | Langan, P, Wan, Q, Coates, L, Kovalevsky, A. | 登録日 | 2012-10-15 | 公開日 | 2014-01-08 | 最終更新日 | 2024-02-28 | 実験手法 | X-RAY DIFFRACTION (1.1 Å) | 主引用文献 | X-ray crystallographic studies of family 11 xylanase Michaelis and product complexes: implications for the catalytic mechanism. Acta Crystallogr.,Sect.D, 70, 2014
|
|
1GOO
 
 | Thermostable xylanase I from Thermoascus aurantiacus - Cryocooled glycerol complex | 分子名称: | ENDO-1,4-BETA-XYLANASE, GLYCEROL | 著者 | Eckert, K, Andrei, C, Larsen, S, Lo Leggio, L. | 登録日 | 2001-10-22 | 公開日 | 2001-12-03 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.87 Å) | 主引用文献 | Substrate Specificity and Subsite Mobility in T. Aurantiacus Xylanase 10A FEBS Lett., 509, 2001
|
|
3N1V
 
 | Human FPPS COMPLEX WITH FBS_01 | 分子名称: | (5-chloro-3-methyl-1-benzothiophen-2-yl)acetic acid, FARNESYL PYROPHOSPHATE SYNTHASE, PHOSPHATE ION | 著者 | Rondeau, J.-M. | 登録日 | 2010-05-17 | 公開日 | 2010-08-18 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.18 Å) | 主引用文献 | Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery. Nat.Chem.Biol., 6, 2010
|
|
1LPP
 
 | |
1H95
 
 | Solution structure of the single-stranded DNA-binding Cold Shock Domain (CSD) of human Y-box protein 1 (YB1) determined by NMR (10 lowest energy structures) | 分子名称: | Y-BOX BINDING PROTEIN | 著者 | Kloks, C.P.A.M, Spronk, C.A.E.M, Hoffmann, A, Vuister, G.W, Grzesiek, S, Hilbers, C.W. | 登録日 | 2001-02-23 | 公開日 | 2002-02-21 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | The Solution Structure and DNA-Binding Properties of the Cold-Shock Domain of the Human Y-Box Protein Yb-1. J.Mol.Biol., 316, 2002
|
|
2CFZ
 
 | Crystal structure of SdsA1, an alkylsulfatase from Pseudomonas aeruginosa, in complex with 1-dodecanol | 分子名称: | 1-DODECANOL, DI(HYDROXYETHYL)ETHER, SDS HYDROLASE SDSA1, ... | 著者 | Hagelueken, G, Adams, T.M, Wiehlmann, L, Widow, U, Kolmar, H, Tuemmler, B, Heinz, D.W, Schubert, W.-D. | 登録日 | 2006-02-26 | 公開日 | 2006-04-26 | 最終更新日 | 2023-12-13 | 実験手法 | X-RAY DIFFRACTION (2.05 Å) | 主引用文献 | The Crystal Structure of Sdsa1, an Alkylsulfatase from Pseudomonas Aeruginosa, Defines a Third Class of Sulfatases. Proc.Natl.Acad.Sci.USA, 103, 2006
|
|
7JSP
 
 | Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZD6738 | 分子名称: | 1,2-ETHANEDIOL, 4-(4-{1-[(R)-amino(hydroxy)methyl-lambda~4~-sulfanyl]cyclopropyl}-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl)-1H-pyrrolo[2,3-b]pyridine, SULFATE ION, ... | 著者 | Karim, M.R, Schonbrunn, E. | 登録日 | 2020-08-15 | 公開日 | 2021-08-25 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain. J.Med.Chem., 65, 2022
|
|
7JKY
 
 | Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with YF3-126 | 分子名称: | Bromodomain-containing protein 4, N-(1-[1,1-di(pyridin-2-yl)ethyl]-6-{1-methyl-6-oxo-5-[(piperidin-4-yl)amino]-1,6-dihydropyridin-3-yl}-1H-indol-4-yl)ethanesulfonamide, SODIUM ION | 著者 | Ratia, K.M, Xiong, R, Li, Y, Shen, Z, Zhao, J, Huang, F, Dubrovyskyii, O, Thatcher, G.R. | 登録日 | 2020-07-29 | 公開日 | 2021-08-25 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.16 Å) | 主引用文献 | Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. J.Med.Chem., 63, 2020
|
|